KOSDAQSemiconductors253590

Neosem

₩15,590▲ 7.15%2026-10-02 close
Market Cap
₩683.5B
Turnover
₩37.7B
Volume
2.4M
Shares out.
43.9M
PER
29.7×
PBR
3.6×
EPS
₩380
Dividend Yield
0.89%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q3–2026Q2) · Dividend yield is based on ₩100 per share · Prices as of the 2026-10-02 close

01

Report overview

SSD Tester Leader Expanding into CXL and HBM

Neosem is a specialist in back-end semiconductor memory test equipment, and its 2Q26 results rebounded the most sharply among the last five quarters, though quarter-to-quarter order volatility remains the key variable for its earnings.

  1. 1

    2Q26 revenue reached KRW 36.0 billion with operating profit of KRW 11.4 billion, a sharp jump from the prior quarter, with operating margin surging to the low-30% range.

  2. 2

    Annual 2025 revenue fell roughly 39% to KRW 63.9 billion from KRW 105.2 billion in 2024, with operating margin compressing from 15.6% to 6.3%.

  3. 3

    Beyond its core Gen5 SSD tester business, the company is diversifying into CXL (1.1 and 2.0 commercialized, 3.1 under development) and HBM burn-in testers, the latter at the QA stage with Samsung Electronics.

  4. 4

    A series of overseas supply contracts through US subsidiary NEOSEM TECHNOLOGY INC. were disclosed from March to May 2026, signaling a resumption of order flow.

  5. 5

    As a small-cap with thin brokerage coverage, the stock carries significant exposure to quarterly earnings volatility and the timing of customer capital expenditure.

02

Business structure

Founded in 2002, Neosem specializes in back-end semiconductor test equipment that verifies the performance and reliability of memory chips during the manufacturing process.

Its business is split largely between SSD (solid-state drive) testers that check performance and reliability, and MBT (monitoring burn-in tester) equipment that subjects memory chips to stress conditions. The company also runs a distribution business for overseas-made assembly machines and particle detectors.

In 2023, Neosem became the first in the world to commercialize a CXL 1.1 memory test device, and it later developed and shipped a CXL 2.0 test device to customers, again a world first.

For HBM (high-bandwidth memory), the company developed a high-temperature stress test device called the 'BX burn-in tester,' which the company has stated is at the quality-assurance (QA) stage with Samsung Electronics.

Its main contracting counterparty is US-based subsidiary NEOSEM TECHNOLOGY INC., while end customers are understood to be global memory makers such as Samsung Electronics and SK Hynix. Most of its revenue comes from exports, exposing results to currency movements.

Domestically, Unitest, TechWing, and Exicon compete in burn-in and module test equipment, with competition increasingly extending into CXL and HBM test equipment as well.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q2₩16.3B₩500M3.0%
2025Q3₩10.2B-₩500M−4.7%
2025Q4₩22.6B₩2.5B11.2%
2026Q1₩14.5B₩600M4.1%
2026Q2₩36B₩11.4B31.7%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩74.7B₩8.4B₩10B11.2%16.1%110.0%
2023₩100.9B₩8.1B₩8.3B8.0%9.5%22.6%
2024₩105.2B₩16.5B₩19.2B15.6%16.6%22.4%
2025₩63.9B₩4.1B₩5.3B6.3%4.5%30.1%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-09-04

04

Earnings analysis

Neosem's annual results grew from KRW 74.7 billion in revenue and KRW 8.4 billion in operating profit (11.2% margin) in 2022 to KRW 105.2 billion in revenue and KRW 16.5 billion in operating profit (15.6% margin) in 2024.

In 2025, however, revenue fell roughly 39% year-over-year to KRW 63.9 billion, and operating profit dropped sharply to KRW 4.1 billion (6.3% margin), with owners' net income shrinking from KRW 19.2 billion to KRW 5.3 billion. The quarterly pattern shows a clear alternation between weakness and recovery.

In 2Q25, revenue was only KRW 16.3 billion with operating profit of KRW 0.5 billion, and the company posted a net loss of KRW 1.6 billion. In 3Q25, revenue fell further to KRW 10.2 billion with an operating loss of KRW 0.5 billion, though net income turned positive at KRW 0.7 billion.

In 4Q25, revenue more than doubled quarter-on-quarter to KRW 22.6 billion, with operating profit of KRW 2.5 billion and net income of KRW 4.4 billion, marking a significant improvement.

Revenue eased again to KRW 14.5 billion in 1Q26 with operating profit of KRW 0.6 billion and net income of KRW 2.3 billion, but 2Q26 delivered the strongest quarter in the recent five-quarter window, with revenue of KRW 36.0 billion, operating profit of KRW 11.4 billion (roughly 31.7% margin), and net income of KRW 8.8 billion.

This large quarter-to-quarter swing in revenue and profit reflects the order-driven nature of the equipment business, where results cluster around the delivery and revenue-recognition timing of large supply contracts.

05

Industry analysis

The back-end semiconductor test equipment industry in which Neosem operates is heavily influenced by shifting memory demand driven by expanding AI server and data center investment.

Demand for high-bandwidth memory and server DRAM has surged due to rising AI demand, and demand for mobile and general-purpose memory is also reported to have picked up quickly from the second half.

Industry participants view CXL, which can substantially expand memory capacity per server, as having become a necessity rather than an option for cloud companies, with test equipment makers expected to capture more value as specifications advance.

Because each AI server built creates an opportunity to sell HBM, CXL, and SSD test equipment, Neosem is positioned across the final test stage of all three categories.

That said, the industry's order flow is dictated by the capital-expenditure decisions and procurement timing of a small number of memory makers, meaning there is typically a lag between a cyclical upturn and its translation into equipment-maker results.

Domestically, competitors such as Unitest, TechWing, and Exicon compete in burn-in and module test equipment, with competition increasingly spreading into CXL and HBM test equipment as well.

06

Outlook

On March 27, 2026, Neosem disclosed a corporate value-up plan centered on SSD and CXL test equipment, committing to continuously enhance performance across next-generation product lines including Gen5/Gen6 SSD, CXL 3.1, CLT, and test automation.

A company representative stated in early October 2025 that development of the CXL 3.1 memory test device had passed 90% completion and was nearly finished, with discussions with customers ongoing.

Indeed, through 2026 a series of overseas supply contracts via US subsidiary NEOSEM TECHNOLOGY INC. were disclosed: a GEN5 SSD tester contract worth KRW 6.21 billion (April 14 to August 31, 2026) on April 14; a GEN6 SSD tester contract worth KRW 4.70 billion (April 3 to November 30, 2026) on April 3; and a GEN6 SSD tester and module contract worth KRW 8.53 billion (May 6 to August 31, 2026) on May 6.

Prior to these, a KRW 14.1 billion test equipment supply contract (November 14, 2025 to June 30, 2026) was also disclosed in November 2025.

On the HBM side, given the company's statement that its BX burn-in tester is at the QA stage with Samsung Electronics, whether this device transitions to mass production is an important point to watch.

On the CXL market, Yole Intelligence has forecast the market to reach $2.1 billion in 2026 and $15 billion by 2028, making it worth monitoring whether test equipment demand expands in line with this.

07

Valuation

PER
29.7×
PBR
3.6×
ROE
13.2%
EPS
₩380
BPS
₩3,109
Dividend per share
₩100

Neosem's share price is trading near the upper end of the historical range established during the 2024 earnings peak, and it is changing hands at a level that reflects a meaningful premium to net asset value.

This can be interpreted as the market partially pricing in the earnings recovery seen in 2Q26 following the sharp contraction in 2025 results.

On the dividend side, the company does pay a partial cash dividend, but the yield itself sits below the sector average, consistent with characteristics typical of a growth-oriented small-cap equipment maker.

With brokerage coverage limited to around two firms, valuation judgments warrant caution given the potential for wide dispersion in future earnings estimates.

Looking at the multi-year pattern of profit growth from 2022 to 2024, contraction in 2025, and recovery in the first half of 2026, it is worth considering where the company currently stands within this earnings cycle.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-09-04

08

Bull factors

Structural Position in Gen5 SSD Testers

Neosem holds proprietary technology as the world's first company to commercialize CXL 1.1 and 2.0 memory test devices, building on a long track record in the SSD tester market.

As AI servers and data centers proliferate, growing demand for storage devices such as eSSDs creates room for related test equipment orders to increase. The series of GEN5 and GEN6 SSD tester supply contracts disclosed through the US subsidiary in 2026 supports the fact that order flow in this business has resumed.

Diversification into CXL and HBM

Neosem is expanding beyond its core SSD tester business into CXL 3.1 development and a BX burn-in tester for HBM. The company has stated that CXL 3.1 development is nearly complete, and the HBM burn-in tester is reported to be at the QA stage with Samsung Electronics.

If these two products transition to mass production, a diversification effect on revenue sources could be expected.

A Clear Earnings Recovery in 2Q26

In 2Q26, revenue reached KRW 36.0 billion with operating profit of KRW 11.4 billion and an operating margin of roughly 31.7%, the strongest quarter in the recent five-quarter window.

This marks a clear rebound from the weakness of the prior quarter and demonstrates the large operating leverage inherent to the order-driven business model. Whether this trend continues will need to be confirmed in future quarterly results.

09

Bear factors

High Quarterly Earnings Volatility

Across the five quarters from 2Q25 to 2Q26, revenue and operating profit swung sharply between losses and gains. The pattern of an operating loss in 3Q, a sharp rebound in 4Q, renewed softness in 1Q, and another rebound in 2Q reflects the structural characteristic of results clustering around order timing. This volatility makes it difficult to draw firm trend conclusions from any single quarter.

Sharp Annual Contraction in 2025

After posting record results in 2024, revenue fell 39% in 2025 and operating margin dropped sharply from 15.6% to 6.3%. This illustrates how directly results are exposed to shifts in customer capital-expenditure timing. The possibility of a similar order gap recurring in the future cannot be ruled out.

Limited Brokerage Coverage

Brokerage coverage of Neosem remains limited to a small number of firms, meaning market consensus formation is relatively constrained. This implies a wider confidence range around earnings estimates and can be a factor that amplifies share price volatility due to information asymmetry.

10

Risk factors

Customer Concentration Risk

Neosem's end customers appear concentrated among a small number of global memory chipmakers such as Samsung Electronics and SK Hynix. If these companies scale back or delay their capital expenditure plans, test equipment orders could be directly affected.

In particular, the HBM burn-in tester remains at the QA stage with Samsung Electronics, leaving the timing and likelihood of a transition to mass production uncertain.

Intensifying Competition Risk

Domestic back-end test equipment companies such as Unitest, TechWing, and Exicon compete in the burn-in and module test market, and competition is also spreading into CXL and HBM test equipment. If competitors commercialize similar products in these newer technology areas, price competition could intensify.

Export Exposure and Order Volatility Risk

Since most of Neosem's revenue comes from exports, fluctuations in the KRW/USD exchange rate can affect its results.

In addition, given the nature of the equipment industry, orders can show a non-linear pattern concentrated in specific quarters, making it difficult to draw firm conclusions about future trends from results in any single period.

11

What to watch next

  1. Mid-November 2026

    The statutory filing deadline for the 3Q26 quarterly report approaches, making it important to check whether the 2Q26 earnings rebound continues.

  2. November 30, 2026

    This marks the end of the contract period for the GEN6 SSD tester supply agreement (KRW 4.70 billion) signed in April 2026, warranting a check on whether follow-on contracts are signed and the scale of revenue recognized.

  3. During 4Q26

    Progress on customer delivery and revenue recognition for the CXL 3.1 mass-production tester should be checked via disclosures or IR materials.

  4. Early 2027

    Whether the HBM BX burn-in tester, currently at the QA stage with Samsung Electronics, advances to mass production should be further monitored.

12

Overall view

Neosem is a back-end semiconductor test equipment specialist that is expanding beyond its core Gen5 SSD tester business into CXL and HBM test equipment.

After sustained profit growth from 2022 to 2024, revenue and operating margin contracted sharply in 2025, and 2026 has shown pronounced quarter-to-quarter swings, with a soft 1Q followed by the strongest quarter in the recent five-quarter window in 2Q.

A series of overseas supply contracts disclosed through its US subsidiary in 2026 signaled a resumption of order flow, and progress on new products such as the CXL 3.1 tester and HBM burn-in tester is cited as a potential mid- to long-term growth driver.

However, with limited brokerage coverage and results heavily dependent on the timing of customer capital expenditure, it will be important to monitor both upcoming quarterly results and the commercialization progress of new products.

Overall, this report does not present an investment opinion or target price and is intended for informational purposes only.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 18 more articles and sources
  1. m.thinkpool.com
  2. news.nate.com
  3. digitaltoday.co.kr
  4. neosem.com
  5. xn--9v2b23mi6ckvf86n.com
  6. m.thinkpool.com
  7. digitaltoday.co.kr
  8. comp.fnguide.com
  9. wcomp.fnguide.com
  10. digitaltoday.co.kr
  11. epnc.co.kr
  12. finance.thesmileinfo.com
  13. alphasquare.co.kr
  14. m.thinkpool.com
  15. m.thinkpool.com
  16. investing.com
  17. w4.kirs.or.kr
  18. alphadistill.com

Report written 2026-09-05 · Data as of 2026-09-04

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.